GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: (S)-(+)-Ketamine | (S)-Ketamine | Spravato®
                                 
                                                         
                            
                            
                            
                                 
                                
                                esketamine is an approved drug (EMA & FDA (2019)) 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: As the ketamine (S) enatiomer esketamine is twice as potent and has a more medically useful pharmacological action than racemic ketamine. Part of this advantage arises from inhibition of dopamine transporters.
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
Classification ![]()  | 
                                                    |
| Compound class | Synthetic organic | 
| Approved drug? | Yes. EU EMA (2019) | US FDA (2019) | 
IUPAC Name ![]()  | 
                                                        
| (2S)-2-(2-chlorophenyl)-2-methylaminocyclohexan-1-one | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 7884 | esketamine | 
Synonyms ![]()  | 
                                                        
| (S)-(+)-Ketamine | (S)-Ketamine | Spravato® | 
Database Links ![]()  | 
                                                        |
| ChEMBL Ligand | CHEMBL395091 | 
| DrugCentral Ligand | 4468 | 
| GtoPdb PubChem SID | 315661237 | 
| PubChem CID | 182137 | 
| RCSB PDB Ligand | JC9 | 
| Search Google for chemical match using the InChIKey | YQEZLKZALYSWHR-ZDUSSCGKSA-N | 
| Search Google for chemicals with the same backbone | YQEZLKZALYSWHR | 
| Search PubMed clinical trials | esketamine | 
| Search PubMed titles | esketamine | 
| Search PubMed titles/abstracts | esketamine | 
| UniChem Compound Search for chemical match using the InChIKey | YQEZLKZALYSWHR-ZDUSSCGKSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | YQEZLKZALYSWHR-ZDUSSCGKSA-N | 
| Wikipedia | Esketamine |